How Does CVS Compare With Amniocentesis for Trisomy 18?
At a Glance
CVS and amniocentesis are both highly accurate diagnostic tests for trisomy 18. CVS can be done earlier but samples placental tissue, while amniocentesis begins at 15 weeks and samples fetal cells more directly, helping avoid placental mosaicism uncertainty.
In this answer
6 sections
Receiving a high-risk screening result—such as from a non-invasive prenatal test (NIPT) or an abnormal ultrasound—can be incredibly stressful. It is important to know that these screening tests assess the risk of a condition but are not diagnoses [1]. To definitively determine if a fetus has trisomy 18, doctors offer diagnostic testing: either Chorionic Villus Sampling (CVS) or amniocentesis [2].
While both are highly accurate diagnostic procedures for analyzing chromosomes, they differ in timing, the specific tissue they sample, and how the results are interpreted.
Quick Comparison
| Feature | Chorionic Villus Sampling (CVS) | Amniocentesis |
|---|---|---|
| Gestational Window | Usually 10 to 13 weeks [3] | From 15 weeks onward [4] |
| Tissue Sampled | Placental tissue (chorionic villi) [5] | Fetal cells found in amniotic fluid [6] |
| Procedure Route | Transabdominal or Transcervical [7] | Transabdominal [8] |
| Main Limitation | Small risk of placental mosaicism requiring follow-up [9] | Must wait until the second trimester [4] |
| Rapid Result (preliminary) | A few days [10] | A few days [11] |
| Full Result (comprehensive) | 1 to 4 weeks depending on the test [12] | 1 to 4 weeks depending on the test [12] |
Timing and Procedure Routes
- CVS is typically performed late in the first trimester, between 10 and 13 weeks of pregnancy [3]. It can be performed through the abdomen (transabdominal) or through the cervix (transcervical), depending on the location of the placenta, the patient’s body type, and the doctor’s experience [7]. It is not performed before 10 weeks due to an increased risk of fetal complications [8][13].
- Amniocentesis is a second-trimester procedure, performed from 15 weeks onward using a needle guided through the abdomen [4]. Early amniocentesis (before 14 to 15 weeks) is avoided because it carries a significantly higher risk of complications and pregnancy loss [8][13].
What Tissue is Sampled?
- CVS collects a sample of chorionic villi, which are microscopic projections of placental tissue [5]. The placenta and the fetus develop from the same fertilized egg, meaning they generally share the same genetic makeup.
- Amniocentesis collects a small amount of amniotic fluid [6]. This fluid contains cells shed directly by the fetus, known as amniocytes [14].
Because amniocentesis samples fetal cells found directly in the amniotic fluid, it provides a more direct representation of the fetus’s genetics [13]. However, it is important to note that while a normal chromosome result from either test significantly lowers the likelihood of genetic conditions, no single test can guarantee a baby will have zero structural, genetic, or developmental issues.
The Challenge of Confined Placental Mosaicism
Because CVS tests placental tissue, it is subject to a biological phenomenon known as confined placental mosaicism (CPM). During early development, genetic differences can become isolated to the placental tissue alone [15].
In roughly 1% to 4% of CVS procedures, the sample shows mosaicism—a mixture of normal cells and cells with a chromosomal abnormality (like trisomy 18) [9][16]. This mosaicism could mean the baby is affected (true fetal mosaicism), or it could simply be CPM, meaning the baby’s actual genetics are completely normal [15]. If a CVS result is mosaic or unclear, doctors usually require a follow-up amniocentesis to accurately determine the baby’s true genetic status [17][18].
Amniocentesis avoids the confusion of confined placental mosaicism, though very rarely it can still encounter interpretation challenges like maternal cell contamination or culture failure [13].
Speed and Types of Results
For both procedures, laboratories offer different levels of testing:
- Rapid Testing: Techniques like QF-PCR or FISH search specifically for common chromosomal anomalies, including trisomy 18. These provide preliminary results in just a few days [10][11].
- Comprehensive Testing: A karyotype requires cells to be grown in a lab, which typically takes 2 to 4 weeks [12]. A chromosomal microarray (CMA) analyzes DNA directly to find smaller genetic changes and may not require cell growth, usually taking 1 to 3 weeks depending on the laboratory [19].
While laboratory testing times are similar for both procedures, choosing CVS means starting the process weeks earlier in the pregnancy, resulting in earlier answers [20].
Procedure-Related Risks and Aftercare
Both CVS and amniocentesis are invasive procedures performed under ultrasound guidance, meaning they carry a small risk of a procedure-related miscarriage.
Historically, CVS was thought to carry a higher risk than amniocentesis. However, contemporary data suggests the excess miscarriage risk caused by either procedure is very low and comparable—estimated around 0.1% to 0.3% above the background pregnancy loss rate when performed by experienced operators [21][22]. Some medical guidelines quote slightly higher, older estimates of 0.5% to 1.0% [23].
Your individual risk will vary based on gestational age, whether you are carrying twins, the procedure route, and the experience of the medical team performing it [24][25].
After the Procedure: Patients typically experience mild cramping. Your doctor will provide strict warning signs to watch for, such as fever, heavy bleeding, severe pain, or fluid leakage, which require immediate medical assessment [13]. If you have an Rh-negative blood type, ask your doctor whether anti-D immunoglobulin is recommended after testing [13].
How to Choose
There is no single universally correct choice [26]. The decision should be made alongside a maternal-fetal medicine specialist or genetic counselor, factoring in your clinical situation (such as placental accessibility or specific ultrasound findings) and your personal values [27][2].
- Consider CVS if: You urgently need diagnostic information for medical planning or peace of mind as early in the pregnancy as possible, and you are emotionally prepared for the small chance that a mosaic result will require you to wait for an amniocentesis anyway [20][2].
- Consider Amniocentesis if: You want the most direct representation of the baby’s genetics, want to completely avoid the ambiguity of placental mosaicism, or if you are already at or beyond 15 weeks of pregnancy [13][2].
Common questions in this guide
What is the main difference between CVS and amniocentesis for trisomy 18?
Is amniocentesis more accurate than CVS for trisomy 18?
Which test gives trisomy 18 results sooner?
What does mosaicism on a CVS result mean?
What is the miscarriage risk from CVS or amniocentesis?
How should I choose between CVS and amniocentesis for trisomy 18?
What symptoms after CVS or amniocentesis need urgent medical attention?
One line in your results can change your plan.
A mosaic or unclear CVS result usually calls for a follow-up amniocentesis to determine the baby's true genetic status. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on Trisomy 18 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (27)
- 1
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
Obstetrics and gynecology 2015; (126(3)):e31-e37 doi:10.1097/AOG.0000000000001051.
PMID: 26287791 - 2
Chorionic Villus Sampling for Rapid Confirmation of High-Risk NIPT Results for Trisomy 21, 18, and 13.
Srebniak MI, Weerts M, Joosten M, et al.
Prenatal diagnosis 2025; (45(8)):988-993 doi:10.1002/pd.6837.
PMID: 40528522 - 3
Chorionic Villi Sampling among Early and Late Gestational Age: Does Timing Affect Yield and Outcomes?
Kim J, Lao A, Rozenblyum A, et al.
AJP reports 2026; (16(2)):e77-e82 doi:10.1055/a-2837-7068.
PMID: 41953865 - 4
Invasive Prenatal Diagnostic Testing for Aneuploidies in Singleton Pregnancies: A Comparative Review of Major Guidelines.
Giovannopoulou E, Tsakiridis I, Mamopoulos A, et al.
Medicina (Kaunas, Lithuania) 2022; (58(10)) doi:10.3390/medicina58101472.
PMID: 36295632 - 5
Epigenome-wide profiling of trisomy 18 specific DNA methylation signatures in first-trimester chorionic villi.
Kim JY, Yang SJ, Kim JW, et al.
Clinical epigenetics 2025; (17(1)):193 doi:10.1186/s13148-025-02018-4.
PMID: 41257854 - 6
Detection of paternal origin of fetal trisomy 18 in a pregnancy conceived by assisted reproductive technology and in vitro fertilization.
Chen CP, Chern SR, Wang LK, et al.
Taiwanese journal of obstetrics & gynecology 2020; (59(4)):607-609 doi:10.1016/j.tjog.2020.05.024.
PMID: 32653139 - 7
Transcervical chorionic villus sampling: a practical guide.
Stergiotou I, Borobio V, Bennasar M, et al.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016; (29(8)):1244-51 doi:10.3109/14767058.2015.1043261.
PMID: 26067265 - 8
Amniocentesis and chorionic villus sampling for prenatal diagnosis.
Alfirevic Z, Navaratnam K, Mujezinovic F
The Cochrane database of systematic reviews 2017; (9()):CD003252 doi:10.1002/14651858.CD003252.pub2.
PMID: 28869276 - 9
Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis.
Malvestiti F, Agrati C, Grimi B, et al.
Prenatal diagnosis 2015; (35(11)):1117-27 doi:10.1002/pd.4656.
PMID: 26213308 - 10
Quantitative fluorescent polymerase chain reaction for rapid prenatal diagnosis of fetal aneuploidies in chorionic villus sampling in a single institution.
Shin YJ, Chung JH, Kim DJ, et al.
Obstetrics & gynecology science 2016; (59(6)):444-453 doi:10.5468/ogs.2016.59.6.444.
PMID: 27896246 - 11
[Comparison of results of improved FISH and conventional karyotyping analysis of 2607 amniotic fluid samples].
Yang Y, Liu Y, Huang N, Xie K
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015; (32(6)):785-8 doi:10.3760/cma.j.issn.1003-9406.2015.06.006.
PMID: 26663048 - 12
Detection of sex chromosome aneuploidies using quantitative fluorescent PCR in the Hungarian population.
Nagy B, Nagy RG, Lazar L, et al.
Clinica chimica acta; international journal of clinical chemistry 2015; (445()):2-6.
PMID: 25791892 - 13
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
Lee JY, Kwon JY, Na S, et al.
Journal of Korean medical science 2021; (36(4)):e26 doi:10.3346/jkms.2021.36.e26.
PMID: 33496085 - 14
Mosaic trisomy 18 at amniocentesis associated with a favorable fetal outcome in a pregnancy.
Chen CP, Hsu TY, Tsai CC, et al.
Taiwanese journal of obstetrics & gynecology 2022; (61(4)):690-694 doi:10.1016/j.tjog.2022.05.006.
PMID: 35779923 - 15
Confined placental mosaicism and its impact on confirmation of NIPT results.
Mardy A, Wapner RJ
American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(2)):118-22 doi:10.1002/ajmg.c.31505.
PMID: 27184347 - 16
Placental mosaicism for autosomal trisomies: comprehensive follow-up of 528 Danish cases (1983-2021).
Thomsen SH, Lund ICB, Bache I, et al.
American journal of obstetrics & gynecology MFM 2024; (6(11)):101497 doi:10.1016/j.ajogmf.2024.101497.
PMID: 39303978 - 17
Chromosomal microarray analysis on uncultured chorionic villus sampling can be complicated by confined placental mosaicism for aneuploidy and microdeletions.
Gu S, Jernegan M, Van den Veyver IB, et al.
Prenatal diagnosis 2018; (38(11)):858-865 doi:10.1002/pd.5342.
PMID: 30094853 - 18
The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure.
Grati FR, Bajaj K, Malvestiti F, et al.
Prenatal diagnosis 2015; (35(10)):994-8 doi:10.1002/pd.4659.
PMID: 26211640 - 19
[Value of chromosomal microarray analysis for the prenatal diagnosis of pregnancy with high risk signaled by non-invasive prenatal testing].
Bu X, Zeng L, Li H, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021; (38(6)):541-544 doi:10.3760/cma.j.cn511374-20200420-00285.
PMID: 34096021 - 20
Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
Scott F, Smet ME, Elhindi J, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (62(4)):497-503 doi:10.1002/uog.26272.
PMID: 37247395 - 21
Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.
Salomon LJ, Sotiriadis A, Wulff CB, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (54(4)):442-451 doi:10.1002/uog.20353.
PMID: 31124209 - 22
Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.
Beta J, Zhang W, Geris S, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (54(4)):452-457 doi:10.1002/uog.20293.
PMID: 30977213 - 23
Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
Wilson RD, Gagnon A, Audibert F, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(7)):656-668 doi:10.1016/S1701-2163(15)30205-X.
PMID: 26366824 - 24
Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study.
Bakker M, Birnie E, Robles de Medina P, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2017; (49(5)):599-606 doi:10.1002/uog.15986.
PMID: 27255564 - 25
Outcome of antenatal invasive diagnostic tests in a fetal medicine unit with low case load in North Wales, United Kingdom.
Gholkar N, Kumar B
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2022; (42(2)):209-214 doi:10.1080/01443615.2021.1904219.
PMID: 34030601 - 26
Using Patient-Centered Care After a Prenatal Diagnosis of Trisomy 18 or Trisomy 13: A Review.
Haug S, Goldstein M, Cummins D, et al.
JAMA pediatrics 2017; (171(4)):382-387 doi:10.1001/jamapediatrics.2016.4798.
PMID: 28192554 - 27
Summary of 2185 prenatal invasive procedures in a single center: A retrospective analysis.
Özcan HÇ, Uğur MG, Sucu S, et al.
Turkish journal of obstetrics and gynecology 2017; (14(2)):114-120 doi:10.4274/tjod.36097.
PMID: 28913147
This comparison is for informational purposes only and does not constitute medical advice. Discuss your trisomy 18 testing options, risks, and results with your maternal-fetal medicine specialist or genetic counselor.